Global Vitiligo Foundation President Seemal Desai, MD, Associate Professor of Clinical Dermatology at the University of Texas-Southwestern in Dallas, TX, and Pearl E. Grimes, MD, Director of the Vitiligo and Pigmentation Institute of Southern California in Los Angeles, CA, have devoted much of their careers to treating vitiligo. In this episode of Prescribing Hope: The Podcast, they discuss the revolution and evolution of vitiligo treatment, spurred by the approval of topical ruxolitinib (Opzelura, Incyte) and bolstered by a robust pipeline.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The Official Dermatology Digest Podcast. Innehållet i podden är skapat av The Official Dermatology Digest Podcast och inte av, eller tillsammans med, Poddtoppen.